1. Home
  2. DK vs QURE Comparison

DK vs QURE Comparison

Compare DK & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

N/A

Current Price

$76.10

Market Cap

3.4B

Sector

Energy

ML Signal

N/A

Logo uniQure N.V.

QURE

uniQure N.V.

N/A

Current Price

$44.51

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DK
QURE
Founded
2001
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.2B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
DK
QURE
Price
$76.10
$44.51
Analyst Decision
Hold
Buy
Analyst Count
17
14
Target Price
$39.94
$45.00
AVG Volume (30 Days)
1.5M
1.1M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.19%
N/A
EPS Growth
95.67
29.67
EPS
N/A
N/A
Revenue
N/A
$13,107,000.00
Revenue This Year
$6.85
$126.12
Revenue Next Year
N/A
$200.43
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.85
$8.73
52 Week High
$77.40
$71.50

Technical Indicators

Market Signals
Indicator
DK
QURE
Relative Strength Index (RSI) 61.95 46.29
Support Level $58.20 $39.50
Resistance Level $77.40 $51.09
Average True Range (ATR) 4.26 2.04
MACD 0.17 -0.69
Stochastic Oscillator 77.92 23.65

Price Performance

Historical Comparison
DK
QURE

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Share on Social Networks: